Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.48 |
| ▸ | ABAT | P80404 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL16267159 | 0.87 | ALDH5A1 (0.60) | ALDH5A1ABATALDH1A1KDM4ECYP2A6 | |
| SCHEMBL10306547 | 0.87 | — | — | |
| SCHEMBL2964 | 0.87 | — | — | |
| Methyl Alcohol SCHEMBL28227404 | 0.85 | CYP2A6 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| SCHEMBL27434835 | 0.85 | PTGS1 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| SCHEMBL27518487 | 0.85 | PTGS1 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| Ammonia Solution, Strong SCHEMBL27779568 | 0.85 | PTGS1 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| SCHEMBL27803389 | 0.85 | PTGS1 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| Hydrochloric Acid SCHEMBL2831797 | 0.85 | PTGS1 (0.52) | ALDH5A1ABATKMT2APTGS1HSD11B1 | |
| Ethylene Glycol SCHEMBL28725363 | 0.81 | KMT2A (0.51) | ALDH5A1ABATKMT2APTGS1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842279-B2 | F-18 peptides for pre targeted positron emission tomography imaging | IMMUNOMEDICS, INC. (US) | 2010-11-30 | — | — | US | disclosed |
| EP-1919515-A2 | F-18 PEPTIDES FOR PRE TARGETED POSITRON EMISSION TOMOGRAPHY IMAGING | Immunomedics, Inc. (US) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007027385-A2 | F-18 PEPTIDES FOR PRE TARGETED POSITRON EMISSION TOMOGRAPHY IMAGING | IMMUNOMEDICS, INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| US-20070048217-A1 | F-18 peptides for pre targeted positron emission tomography imaging | IMMUNOMEDICS, INC. | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070048217-A1 | F-18 peptides for pre targeted positron emission tomography imaging | SSTR4, NPPA, ANPEP | ALDH5A1 2718/4885ABAT 1635/4885KMT2A 3120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.